Eczematous drug eruption from carbamazepine: coexistence of contact and photocontact sensitivity
- 11 April 1989
- journal article
- research article
- Published by Wiley in Contact Dermatitis
- Vol. 20 (4) , 260-264
- https://doi.org/10.1111/j.1600-0536.1989.tb03142.x
Abstract
We report a 46-year-old patient with an eczematous eruption on sun-exposed areas which we believe was caused by carbamazepine intake. Oral provocation with the drug produced papulo-vesicular eruption that were greatly potentiated by long-wave ultraviolet irradiation. Positive reactions to carbamazepine were elicited by patch and photopatch tests and by lymphocyte stimulation tests 6 months after cessation of the intake of carbamazepine.Keywords
This publication has 15 references indexed in Scilit:
- Patch test diagnosis in carbamazepine erythrodermaContact Dermatitis, 1986
- Carbamazepine ('Tegretol') and toxic epidermal necrolysis: report of three cases with histopathological observationsClinical and Experimental Dermatology, 1982
- Deposits of Plasma Proteins in the Skin during Treatment with Carbamazepine and DiphenylhydantoinActa Medica Scandinavica, 1977
- CarbamazepineAnnals of Internal Medicine, 1973
- The Mechanism of Photoallergic Contact Dermatitis**From the Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.Journal of Investigative Dermatology, 1968
- Carbamazepine (Tegretol) drug eruptionsBritish Journal of Dermatology, 1967
- "Collagen disease" due to carbamazepine (Tegretol).BMJ, 1966
- FURTHER EXPERIENCES WITH HALOGENATED SALICYLANILIDES.British Journal of Dermatology, 1962
- Allergic Photocontact Dermatitis from Promethazine (Phenergan)Archives of Dermatology, 1960
- Photoallergy and Photocross-Sensitivity to Phenergan1Journal of Investigative Dermatology, 1957